This is unpublished

Ajay K.

he, him, his
Physician & Research Faculty
Professor, Division of Medical Oncology, University of Washington
Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Director of Clinical Research, Hematologic Malignancies/Hematology, Fred Hutch / UW Cancer Consortium
Associate Medical Director, Hematologic Malignancies/Hematology, Seattle Cancer Care Alliance
Clinical Research Director, Hematologic Malignancies/Hematology, Myeloma and Lymphoma Oncology, UW Medicine
Sites of Practice
Seattle Cancer Care Alliance

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Emory University School of Medicine
  • Residency in Internal Medicine, Duke University  
  • Fellowship in Medical Oncology, Fred Hutch/UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine

Clinical Expertise

  • Lymphoma 
  • Chronic lymphocytic leukemia (CLL)
  • Hematologic malignancies 
  • Hematologic stem cell transplantation and cellular therapy
  •  Radioimmunotherapy




Research and/or clinical interests:  

Dr. Ajay Gopal develops new targeted treatments for patients with lymphoma. He is director of clinical research in hematological malignancies and hematology at Seattle Cancer Care Alliance, Fred Hutch’s clinical-care partner. 


Dr. Gopal’s research focuses on developing novel targeted therapies for lymphomas with particular emphasis on immunotherapeutic strategies, low toxicity, proapoptotic agents for indolent lymphomas, and safer regimens for older adults with lymphoma.